Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
0(0%)
Results Posted
29%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_3
2
20%
Ph phase_4
3
30%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 32 (25.0%)
Phase 43 (37.5%)
N/A2 (25.0%)

Trials by Status

completed770%
terminated220%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10